U.S. Physical Therapy (USPH) Set to Announce Earnings on Tuesday

U.S. Physical Therapy (NYSE:USPH) will issue its quarterly earnings data after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.58 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Wednesday, February 28th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.57 by $0.02. U.S. Physical Therapy had a net margin of 4.67% and a return on equity of 8.52%. The business had revenue of $154.80 million during the quarter, compared to analyst estimates of $150.24 million. During the same quarter in the previous year, the business posted $0.58 EPS. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

U.S. Physical Therapy Trading Up 1.5 %

NYSE:USPH opened at $105.20 on Friday. The firm has a 50 day moving average of $105.10 and a 200 day moving average of $96.01. The stock has a market capitalization of $1.59 billion, a price-to-earnings ratio of 77.93, a PEG ratio of 4.92 and a beta of 1.39. The company has a quick ratio of 2.28, a current ratio of 2.28 and a debt-to-equity ratio of 0.29. U.S. Physical Therapy has a 52 week low of $78.08 and a 52 week high of $124.11.

U.S. Physical Therapy Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 5th. Investors of record on Tuesday, March 12th were paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a yield of 1.67%. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.43. The ex-dividend date was Monday, March 11th. U.S. Physical Therapy’s payout ratio is 130.37%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on USPH. Barrington Research lifted their target price on shares of U.S. Physical Therapy from $120.00 to $122.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st. JPMorgan Chase & Co. lifted their price objective on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 13th. Finally, StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, U.S. Physical Therapy has an average rating of “Moderate Buy” and a consensus target price of $125.67.

Insider Activity at U.S. Physical Therapy

In other news, CFO Carey P. Hendrickson sold 1,800 shares of the stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total transaction of $193,104.00. Following the sale, the chief financial officer now directly owns 21,186 shares of the company’s stock, valued at approximately $2,272,834.08. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other U.S. Physical Therapy news, EVP Richard Binstein sold 2,000 shares of the firm’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $106.55, for a total value of $213,100.00. Following the transaction, the executive vice president now owns 15,006 shares in the company, valued at approximately $1,598,889.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Carey P. Hendrickson sold 1,800 shares of the company’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $107.28, for a total transaction of $193,104.00. Following the sale, the chief financial officer now directly owns 21,186 shares of the company’s stock, valued at approximately $2,272,834.08. The disclosure for this sale can be found here. Insiders sold 10,829 shares of company stock worth $1,141,535 over the last three months. Company insiders own 1.80% of the company’s stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.